Press release
Non-Hodgkin lymphoma treatment Market Size, Trends, Global Industry Report to 2019-2025
The global Non-Hodgkin lymphoma treatment market is anticipated to grow at a significant CAGR during the forecast period. The Non-Hodgkin lymphoma cancer is more common with high prevalence which will drive the Non-Hodgkin lymphoma treatment industry considerably. Non-Hodgkin lymphoma shows constitutional symptoms as well as hepatosplenomegaly symptoms. Constitutional symptoms include weight loss, hyperhidrosis, generalized hyperhidrosis, chronic pain, fatigue, and malaise. Whereas hepatosplenomegaly symptoms include abdominal pain, swelling or tenderness, nausea and vomiting, fever.Get Free Sample Copy @ https://www.omrglobal.com/request-sample/non-hodgkin-lymphoma-treatment-market
Some lymphomas will secrete Immunoglobulin M (IgM) which leads to hyperviscosity syndrome as well as autoimmune cytopenia. Hence, rise in autoimmune diseases across the globe will significantly drive the Non-Hodgkin lymphoma treatment market. The non-Hodgkin lymphomas also secrete gammaglobulinemia which leads to infectious diseases. Thus, the increasing infection will also drive the market.
A Full Report of Global Non-Hodgkin lymphoma treatment Market is Available at: https://www.omrglobal.com/industry-reports/non-hodgkin-lymphoma-treatment-market
Additionally, Non-Hodgkin lymphoma is the second most common cancer in patients with AIDS. According to the World Health Organization, 37.9 million people are living with HIV in 2018 across the globe. People living with HIV are about ten times more likely to develop Non-Hodgkin lymphoma than people without HIV. Hence the increasing AIDS cases across the globe is likely to drive the Non-Hodgkin lymphoma treatment market significantly.
Moreover, the risk of developing Non-Hodgkin lymphoma is significantly high after organ transplant as the patient’s immunity becomes weak after the transplantation. Therefore, the increase in organ transplantation activities will also fuel the Non-Hodgkin lymphoma treatment market. In addition to this, immunosuppressed as well as congenital immune deficiency patients are also at high risk of developing Non-Hodgkin lymphoma. Hence, the patient pool of these kind of diseases will significantly impact the Non-Hodgkin lymphoma treatment industry size.
Additionally, the increasing use of radiation and chemotherapy as the first line of treatment in lymphoma cancer will also impact the Non-Hodgkin lymphoma treatment market growth. Besides, the development and advancements of therapies such as CAR-T cells are also anticipated to drive the market during the forecast period.
Global Non-Hodgkin Lymphoma Treatment Market- Segmentation
By Cell Type
B-Cell
T-Cell
By Therapy Type
Chemotherapy
Radiation
Others
Global Non-Hodgkin Lymphoma Treatment Market- Segment by Region
North America
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
AbbVie Inc.
Amgen Inc.
AstraZeneca PLC
Bayer AG
Bristol Myers Squibb Co.
Eli Lilly and Co.
Epizyme, Inc.
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline PLC
Johnson & Johnson Services Inc.
Merck & Co., Inc.
Nordic Nanovector ASA
Novartis International AG
Pfizer Inc.
Sanofi SA
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-hodgkin-lymphoma-treatment-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Hodgkin lymphoma treatment Market Size, Trends, Global Industry Report to 2019-2025 here
News-ID: 2081754 • Views: …
More Releases from Orion Market Research
Industrial 3D Printing Market Set to Witness Significant Growth by 2033 | EOS Gm …
The global Industrial 3D Printing Market was valued at approximately USD 3.56 billion in 2024, and is projected to reach around USD 19.85 billion by 2033, growing at a CAGR of about 21.0% during 2025 to 2033.
🔍 Industrial 3D Printing Market Overview
The industrial 3D printing market is experiencing rapid growth as manufacturers across sectors-including automotive, aerospace, healthcare, and defense-adopt additive manufacturing for rapid prototyping, tooling, and end-use parts production. These…
Healthcare Digital Signage Market Size Future Scope, Demands and Projected Indus …
The global Healthcare Digital Signage Market was valued at approximately USD 6.23 billion in 2023, and is projected to reach around USD 19.70 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 10.61% from 2024 to 2033.
Healthcare Digital Signage Market Overview
The Healthcare Digital Signage Market is gaining strong momentum as hospitals, clinics, and medical facilities increasingly deploy interactive displays to enhance communication, patient engagement, and wayfinding.…
Electric Scooters Market Size Analysis, Competitive Insights, Leading Players an …
The global Electric Scooters Market was valued at approximately USD 38.24 billion in 2023 and is projected to reach around USD 102.07 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 10.32% from 2023 to 2033.
Electric Scooters Market Overview
The electric scooters market is experiencing a robust upswing as eco-conscious consumers, urban congestion challenges, and favorable government incentives drive increased adoption globally. Technological advancements-particularly in battery efficiency, lightweight…
Hydrogen Generation Market Set to Witness Significant Growth by 2033 | Cummins I …
The global Hydrogen Generation Market was valued at approximately USD 172.5 billion in 2024, and is anticipated to grow to USD 272.4 billion by 2033, reflecting a compound annual growth rate (CAGR) of 5.14% between 2025 and 2033.
🔍 Hydrogen Generation Market Overview:
The hydrogen generation sector is experiencing robust expansion driven by surging demand for clean energy, industrial decarbonization initiatives, and broad adoption in transportation, power generation, refining, and chemical industries.…
More Releases for HIV
HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792
This latest report researches the industry structure, sales, revenue,…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
